Annovis Net Income From Continuing Ops from 2010 to 2024

ANVS Stock  USD 6.65  0.14  2.06%   
Annovis Bio Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss is likely to outpace its year average in 2024. From the period from 2010 to 2024, Annovis Bio Net Loss quarterly data regression had r-value of (0.78) and coefficient of variation of (164.25). View All Fundamentals
 
Net Loss  
First Reported
2012-12-31
Previous Quarter
-5 M
Current Value
-12.6 M
Quarterly Volatility
5.4 M
 
Yuan Drop
 
Covid
Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers, such as Interest Expense of 199.6 K, Selling General Administrative of 6.6 B or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules.
  
Check out the analysis of Annovis Bio Correlation against competitors.
For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Latest Annovis Bio's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Annovis Bio over the last few years. It is Annovis Bio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Annovis Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(8,920,421)
Geometric Mean0.00
Coefficient Of Variation(164.25)
Mean Deviation11,397,645
Median(713,871)
Standard Deviation14,651,706
Sample Variance214.7T
Range41.7M
R-Value(0.78)
Mean Square Error91.3T
R-Squared0.60
Significance0.0006
Slope(2,548,263)
Total Sum of Squares3005.4T

Annovis Net Income From Continuing Ops History

2024-39.6 M
2023-41.7 M
2022-25.3 M
2021-14.5 M
2020-5.5 M
2019-991 K
2018-713.9 K

About Annovis Bio Financial Statements

Annovis Bio shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Annovis Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-41.7 M-39.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.